Emerging Biomarkers Shaping The Next Generation of Oncology Drug Development For biopharma teams advancing next-generation oncology therapies, high-priority targets across ADCs, immune-modulating molecules, and metabolic pathways are shaping new development strategies. This white paper explores how biomarker insights can support target validation, patient selection, trial design, resistance monitoring, and commercial planning. mcottam Tue, 08/25/2026 - 13:44 For
CryptoAlerta — análise de criptomoedas e mercado em tempo real